SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001943
Filing Date
2024-11-13
Accepted
2024-11-13 17:11:12
Documents
86
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20240930x10q.htm   iXBRL 10-Q 2066262
2 EX-3.2 tmb-20240930xex3d2.htm EX-3.2 17064
3 EX-10.1 tmb-20240930xex10d1.htm EX-10.1 30229
4 EX-31.1 tmb-20240930xex31d1.htm EX-31.1 14306
5 EX-31.2 tmb-20240930xex31d2.htm EX-31.2 14259
6 EX-32 tmb-20240930xex32.htm EX-32 12921
  Complete submission text file 0001410578-24-001943.txt   8878579

Data Files

Seq Description Document Type Size
7 EX-101.SCH tmb-20240930.xsd EX-101.SCH 72627
8 EX-101.CAL tmb-20240930_cal.xml EX-101.CAL 58434
9 EX-101.DEF tmb-20240930_def.xml EX-101.DEF 203675
10 EX-101.LAB tmb-20240930_lab.xml EX-101.LAB 573483
11 EX-101.PRE tmb-20240930_pre.xml EX-101.PRE 396157
89 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20240930x10q_htm.xml XML 1562582
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

IRS No.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39752 | Film No.: 241455597
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)